- Home
- NMAX vs XENE Comparison
NMAX vs XENE Comparison
Compare NMAX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMAX
- XENE
- Stock Information
- Founded
- NMAX 1998
- XENE 1996
- Country
- NMAX United States
- XENE Canada
- Employees
- NMAX N/A
- XENE 327
- Industry
- NMAX
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NMAX
- XENE Health Care
- Exchange
- NMAX NYSE
- XENE Nasdaq
- Market Cap
- NMAX 3.0B
- XENE 2.3B
- IPO Year
- NMAX 2025
- XENE 2014
- Fundamental
- Price
- NMAX $18.30
- XENE $28.85
- Analyst Decision
- NMAX
- XENE Strong Buy
- Analyst Count
- NMAX 0
- XENE 11
- Target Price
- NMAX N/A
- XENE $54.82
- AVG Volume (30 Days)
- NMAX 1.1M
- XENE 1.5M
- Earning Date
- NMAX 05-15-2025
- XENE 05-12-2025
- Dividend Yield
- NMAX N/A
- XENE N/A
- EPS Growth
- NMAX N/A
- XENE N/A
- EPS
- NMAX N/A
- XENE N/A
- Revenue
- NMAX $175,718,517.00
- XENE $7,500,000.00
- Revenue This Year
- NMAX N/A
- XENE N/A
- Revenue Next Year
- NMAX N/A
- XENE $611.23
- P/E Ratio
- NMAX N/A
- XENE N/A
- Revenue Growth
- NMAX 20.18
- XENE N/A
- 52 Week Low
- NMAX $14.00
- XENE $26.74
- 52 Week High
- NMAX $265.00
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- NMAX N/A
- XENE 34.31
- Support Level
- NMAX N/A
- XENE $29.38
- Resistance Level
- NMAX N/A
- XENE $31.74
- Average True Range (ATR)
- NMAX 0.00
- XENE 1.34
- MACD
- NMAX 0.00
- XENE -0.31
- Stochastic Oscillator
- NMAX 0.00
- XENE 7.53
About NMAX NEWSMAX INC
Newsmax Inc is a multi-platform media company. The company provides original news and lifestyle updates from its linear cable television and over-the-top (OTT) news channels, websites, proprietary database, publishing products, and e-commerce products. The Company uses original news and editorial content to draw large numbers of readers to its media outlets to sell advertising, print, and online information products. The Company's business operations are conducted through two operating segments, Broadcasting and Digital. The company generates maximum revenue from the Broadcasting Segment.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.